Skip to main content

Table 6 Capital of asthma revolving drug fund in Benin, as of January 2013

From: Assessment of a revolving drug fund for essential asthma medicines in Benin

 

Total amount (€)

1. Balance in Bank (a + b-c)

8,414

  a) Grant in cash

5,428

  b) Monies recovered from medicines

32,211*

  c) Expenditure

29,225†

2. Value of inhalers in stock

12,172‡

Total (1 + 2)

20,586

  1. *See Table 5, money already recovered.
  2. †See Table 3, total expenditure.
  3. ‡See Table 5, ADF inhalers in stock.